Squarepoint’s Apollo Endosurgery, Inc. APEN Stock Holding History

Squarepoint’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,658	Closed	-$126K	–	3987
2022 Q4	$126K	Buy	+12,658	New	+$94.4K	﹤0.01%	2920

Other funds holding APEN

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Squarepoint's APEN Position: Q1 2023 in Review

Squarepoint sold out of Apollo Endosurgery, Inc. (APEN) in Q1 2023, closing a stake of 12,658 shares — an estimated $126K sold.

Squarepoint first reported a position in APEN in Q4 2022 and held it in 1 quarter. The position peaked at $126K in Q4 2022. 89 funds tracked by Wall St. Rank hold APEN as of Q1 2023.

Squarepoint reported no remaining Apollo Endosurgery, Inc. position as of Q1 2023 after selling out during the quarter.
Squarepoint sold 12,658 Apollo Endosurgery, Inc. shares in Q1 2023, an estimated $126K.
Squarepoint first reported a position in Apollo Endosurgery, Inc. in Q4 2022 and held it in 1 quarter.
Squarepoint's Apollo Endosurgery, Inc. position peaked at $126K in Q4 2022.
89 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2023.

Based on Squarepoint's 13F filing for Q1 2023, filed 15 May 2023.